Abstract
Oral anticoagulant therapy, such as vitamin K antagonists (VKAs), is prominent for the prevention of cerebral ischemic stroke or systemic embolism and all-cause mortality in patients with atrial fibrillation, venous thromboembolism, and mechanical or biological valve. VKA treatment requires monitoring of the international normalized ratio (INR) in order to maintain it in a therapeutic range, avoiding side effects, the main and most significant of which is bleeding. The aim of the present study was to evaluate the event rates of several clinical composite outcomes, such as bleeding, thromboembolic events, and all-cause death. We compared three organizational models distinguished by a total (from 1 January to 31 December 2015 in which PT/INR analysis with the relative internal and external quality controls was performed by the surveillance center) or partial (from 15 January to 15 July 2016 and from 15 August to 15 November 2016, in which the surveillance center had the ability to view only the PT/INR results or all patients analyses, including blood count, creatinine, liver enzymes, etc., respectively) analytical patient management. The present longitudinal follow-up study included 1225 patients, recruited from 1 January 2015 to...Continue Reading
References
Aug 1, 1990·Archives of Internal Medicine·J E Wipf, B A Lipsky
Apr 5, 2001·The New England Journal of Medicine·R H Falk
Dec 15, 2004·Chest·Matthew W ReynoldsLuba Nalysnyk
Apr 22, 2005·Journal of Thrombosis and Haemostasis : JTH·S SchulmanUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Jul 11, 2007·Archives of Internal Medicine·Diane K WysowskiLynette Swartz
Jul 20, 2007·Circulation·David J Schneider, Burton E Sobel
Aug 19, 2007·Lancet·Jonathan MantUNKNOWN Midland Research Practices Network (MidReC)
Jul 1, 2008·American Heart Journal·Stephan RietbrockTjeerd van Staa
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Sep 19, 2009·Chest·Gregory Y H LipHarry J G M Crijns
Feb 16, 2010·The American Journal of Cardiology·Jan MenkeJörg Larsen
Oct 12, 2010·Journal of cardiology·Hirotsugu AtarashiUNKNOWN J-RHYTHM Registry Investigators
Feb 2, 2011·BMJ : British Medical Journal·Jonas Bjerring OlesenChristian Torp-Pedersen
May 28, 2011·European Heart Journal·Mattias WielochPeter J Svensson
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 30, 2011·The New England Journal of Medicine·Christopher B GrangerUNKNOWN ARISTOTLE Committees and Investigators
Mar 19, 2013·BMC Health Services Research·Kerstin ArbringTomas L Lindahl
Nov 21, 2013·The New England Journal of Medicine·Robert P GiuglianoUNKNOWN ENGAGE AF-TIMI 48 Investigators
Feb 20, 2014·Thrombosis Journal·Mauro Molteni, Claudio Cimminiello
Apr 16, 2014·BMJ : British Medical Journal·Benjamin A Steinberg, Jonathan P Piccini
Sep 29, 2015·European Journal of Inflammation·N TidjaneR Couture
Nov 26, 2015·International Journal of Immunopathology and Pharmacology·Enrica BianchiMarco Artico
Dec 5, 2015·International Journal of Immunopathology and Pharmacology·Alicja Kasperska-ZajacZbigniew Kalarus
Apr 6, 2016·International Journal of Immunopathology and Pharmacology·A MascaliM Tesauro
Jun 30, 2016·Journal of Arrhythmia·Ahmed AlTurkiVidal Essebag
Oct 4, 2016·International Journal of Immunopathology and Pharmacology·Mohamed H MahmoudNashwa A El Shinnawy